Lcn2 transcription has already been shown to be dependent on NF-κB activation in breast and thyroid cancer cells [2,10,11] and NF-κB has been shown to bind to the Lcn2 promoter [11]. The gene discussed is NFKB1; the disease is thyroid gland carcinoma.